A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
for Macular Degeneration
51 locations incl. Scottsdale
Sponsor: EyeBiotech Ltd.
Sex: All·Age: 50+
Code: NCT07440225·Phase 2, Phase 3·Recruiting·Listed Feb 2026
Vitreo Retinal Associates
Clinical research site in Gainesville, Florida · 4340 W NEWBERRY RD STE 202, GAINESVILLE, FL 32607-2557 · (352) 371-2800
As of July 2026, 9 paid clinical trials are recruiting at Vitreo Retinal Associates in Gainesville, Florida. Active studies at this site cover conditions such as Stargardt Disease, Cone Rod Dystrophy and Juvenile Macular Degeneration. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Vitreo Retinal Associates (9)
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for Geographic Atrophy
15 locations incl. Peoria
Sponsor: Sanofi
Sex: All·Age: 60+
Code: NCT07215234·Phase 1, Phase 2·Recruiting·Listed Oct 2025
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
for Retinitis Pigmentosa
14 locations incl. Phoenix
Sponsor: jCyte, Inc
Sex: All·Age: 18 - 60
Code: NCT06912633·Phase 2·Recruiting·Listed Apr 2025
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
for Neovascular (Wet) Age-Related Macular Degeneration
19 locations incl. Phoenix
Sponsor: 4D Molecular Therapeutics
Sex: All·Age: 50+
Code: NCT05197270·Phase 1, Phase 2·Recruiting·Listed Jan 2022
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
for Stargardt Disease
10 locations incl. San Francisco
Sponsor: Ascidian Therapeutics, Inc
Sex: All·Age: 12+
Code: NCT06467344·Phase 1, Phase 2·Recruiting·Listed Jun 2024
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
for Stargardt
14 locations incl. San Diego
Sponsor: Splice Bio
Sex: All·Age: 12 - 65
Code: NCT06435000·Recruiting·Listed May 2024
Study of ALK-001 on the Progression of Stargardt Disease
for Stargardt Disease
5 locations incl. Phoenix
Sponsor: Alkeus Pharmaceuticals, Inc.
Sex: All·Age: 8 - 45
Code: NCT07419334·Phase 3·Recruiting·Listed Feb 2026
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
for ARB
4 locations incl. Los Angeles
Sponsor: Opus Genetics, Inc
Sex: All·Age: 18+
Code: NCT07185256·Phase 1, Phase 2·Recruiting·Listed Sep 2025
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
for Stargardt Disease
8 locations incl. San Francisco
Sponsor: Ascidian Therapeutics, Inc
Sex: All·Age: 5+
Code: NCT06445322·Recruiting·Listed Jun 2024
More research sites in Gainesville
- University of Florida (211 trials)
- UF Health Cancer Institute - Gainesville (44 trials)
- University of Florida Health (12 trials)
- North Florida/South Georgia Veterans Health System, Gainesville, FL (11 trials)
- University of Florida College of Medicine (9 trials)
- Malcom Randall Veterans Administration Medical Center (8 trials)
- UF Health (7 trials)
- UF Health Shands Hospital (6 trials)
- Norman Fixel Institute for Neurological Diseases (6 trials)
- The Cardiac and Vascular Institute (6 trials)
Explore more
Paid clinical trials in Gainesville, FL · Florida clinical trials